Qiagen (QIA) Stock Forecast & Price Target

Compare

10 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QIA Analyst Ratings

Moderate Buy

7 Buy

5 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QIA Stock 12 Month Forecast

Average Price Target

€45.27

▲(5.85% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is €45.27 with a high forecast of €50.04 and a low forecast of €39.03. The average price target represents a 5.85% change from the last price of €42.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"€35","39":"€39","43":"€43","47":"€47","51":"€51"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50.0379216436,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€50.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45.272817111,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€45.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":39.0288870338,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€39.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,39,43,47,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.067,41.75707089566154,42.44714179132308,43.13721268698462,43.82728358264615,44.517354478307695,45.20742537396923,45.89749626963077,46.587567165292306,47.27763806095385,47.96770895661538,48.657779852276924,49.347850747938466,{"y":50.0379216436,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.067,41.39052439315385,41.71404878630769,42.03757317946154,42.361097572615385,42.68462196576923,43.00814635892308,43.331670752076924,43.65519514523077,43.97871953838462,44.30224393153846,44.62576832469231,44.949292717846156,{"y":45.272817111,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.067,40.91022207952307,40.753444159046154,40.59666623856923,40.43988831809231,40.28311039761538,40.12633247713846,39.969554556661535,39.812776636184616,39.65599871570769,39.49922079523077,39.34244287475384,39.18566495427692,{"y":39.0288870338,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":37.631,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.213,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.885,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.487,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.532,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.467,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.83,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.674,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.64,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.943,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.56,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.251,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.067,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€50.04

Average Price Target€45.27

Lowest Price Target€39.03

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Harry GillisBerenberg Bank

Berenberg Bank

€50

Buy

16.90%

Upside

Reiterated

07/31/25

Qiagen (QGEN) Gets a Buy from Berenberg Bank

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah NoorMorgan Stanley

Morgan Stanley

€43

Hold

0.54%

Upside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Michael RyskinBank of America Securities

Bank of America Securities

€45.8

Buy

7.08%

Upside

Reiterated

07/18/25

Qiagen (QGEN) Gets a Buy from Bank of America Securities

Daniel BrennanTD Cowen

TD Cowen

€42.34

Hold

-1.01%

Downside

Reiterated

07/16/25

Jan KochDeutsche Bank

Deutsche Bank

―

Buy

―

Reiterated

07/08/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Luke SergottBarclays

Barclays

€47.52

Buy

11.12%

Upside

Initiated

06/24/25

Qiagen initiated with an Overweight at BarclaysQiagen initiated with an Overweight at Barclays

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Reiterated

05/21/25

Cautious Optimism for Qiagen Amidst Industry Challenges: Awaiting Long-term Growth Assurance

Patrick B DonnellyCiti

Citi

€47.52

Buy

11.12%

Upside

Assigned

05/20/25

Qiagen's Strong Positioning and Growth Potential Earns Buy Rating from Analyst

Maja PatakiKepler Capital

Kepler Capital

€39

Hold

-8.81%

Downside

Reiterated

05/20/25

Qiagen (QGEN) Receives a Hold from Kepler Capital

Tycho PetersonJefferies

Jefferies

€46.66

Buy

9.10%

Upside

Reiterated

05/12/25

Jefferies Keeps Their Buy Rating on Qiagen (QGEN)

Dan LeonardUBS

UBS

―

Hold

―

Reiterated

05/09/25

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (NASDAQ: TRVI), Pliant Therapeutics (NASDAQ: PLRX) and Qiagen (NYSE: QGEN)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

€38.88

Hold

-9.09%

Downside

Reiterated

04/24/25

Analysts Conflicted on These Healthcare Names: Qiagen (NYSE: QGEN) and Viking Therapeutics (NASDAQ: VKTX)

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

€36.29→€37.16

Hold

-13.13%

Downside

Reiterated

04/21/25

Qiagen price target raised to $43 from $42 at BairdQiagen price target raised to $43 from $42 at Baird

Ed Ridley-DayRedburn Atlantic

Redburn Atlantic

€47→€41

Hold

-4.14%

Downside

Downgraded

04/04/25

Qiagen downgraded to Neutral from Buy at Redburn AtlanticQiagen downgraded to Neutral from Buy at Redburn Atlantic

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Harry GillisBerenberg Bank

Berenberg Bank

€50

Buy

16.90%

Upside

Reiterated

07/31/25

Qiagen (QGEN) Gets a Buy from Berenberg Bank

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah NoorMorgan Stanley

Morgan Stanley

€43

Hold

0.54%

Upside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Michael RyskinBank of America Securities

Bank of America Securities

€45.8

Buy

7.08%

Upside

Reiterated

07/18/25

Qiagen (QGEN) Gets a Buy from Bank of America Securities

Daniel BrennanTD Cowen

TD Cowen

€42.34

Hold

-1.01%

Downside

Reiterated

07/16/25

Jan KochDeutsche Bank

Deutsche Bank

―

Buy

―

Reiterated

07/08/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Luke SergottBarclays

Barclays

€47.52

Buy

11.12%

Upside

Initiated

06/24/25

Qiagen initiated with an Overweight at BarclaysQiagen initiated with an Overweight at Barclays

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Reiterated

05/21/25

Cautious Optimism for Qiagen Amidst Industry Challenges: Awaiting Long-term Growth Assurance

Patrick B DonnellyCiti

Citi

€47.52

Buy

11.12%

Upside

Assigned

05/20/25

Qiagen's Strong Positioning and Growth Potential Earns Buy Rating from Analyst

Maja PatakiKepler Capital

Kepler Capital

€39

Hold

-8.81%

Downside

Reiterated

05/20/25

Qiagen (QGEN) Receives a Hold from Kepler Capital

Tycho PetersonJefferies

Jefferies

€46.66

Buy

9.10%

Upside

Reiterated

05/12/25

Jefferies Keeps Their Buy Rating on Qiagen (QGEN)

Dan LeonardUBS

UBS

―

Hold

―

Reiterated

05/09/25

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (NASDAQ: TRVI), Pliant Therapeutics (NASDAQ: PLRX) and Qiagen (NYSE: QGEN)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

€38.88

Hold

-9.09%

Downside

Reiterated

04/24/25

Analysts Conflicted on These Healthcare Names: Qiagen (NYSE: QGEN) and Viking Therapeutics (NASDAQ: VKTX)

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

€36.29→€37.16

Hold

-13.13%

Downside

Reiterated

04/21/25

Qiagen price target raised to $43 from $42 at BairdQiagen price target raised to $43 from $42 at Baird

Ed Ridley-DayRedburn Atlantic

Redburn Atlantic

€47→€41

Hold

-4.14%

Downside

Downgraded

04/04/25

Qiagen downgraded to Neutral from Buy at Redburn AtlanticQiagen downgraded to Neutral from Buy at Redburn Atlantic

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

1 Month

xxx

Success Rate

8/13 ratings generated profit

Average Return

+1.88%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +1.88% per trade.

3 Months

xxx

Success Rate

11/17 ratings generated profit

Average Return

+2.94%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +2.94% per trade.

1 Year

Michael RyskinBank of America Securities

Success Rate

10/11 ratings generated profit

Average Return

+9.77%

reiterated a buy rating 20 days ago

Copying Michael Ryskin's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +9.77% per trade.

2 Years

xxx

Success Rate

11/11 ratings generated profit

Average Return

+13.87%

reiterated a xxx

rating 20 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +13.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QIA Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QIA has received 22 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. QIA average Analyst price target in the past 3 months is 45.27.

Each month's total comprises the sum of three months' worth of ratings.

QIA Financial Forecast

QIA Earnings Forecast

Next quarter’s earnings estimate for QIA is €0.50 with a range of €0.48 to €0.52. The previous quarter’s EPS was €0.52. QIA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 47.50% of the time in the same period. In the last calendar year QIA has Preformed in-line its overall industry.

QIA Sales Forecast

Next quarter’s sales forecast for QIA is €446.69M with a range of €442.62M to €452.13M. The previous quarter’s sales results were €461.64M. QIA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.00% of the time in the same period. In the last calendar year QIA has Preformed in-line its overall industry.

QIA Stock Forecast FAQ

What is DE:QIA’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen’s 12-month average price target is 45.27.

What is DE:QIA’s upside potential, based on the analysts’ average price target?

Qiagen has 5.85% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Qiagen a Buy, Sell or Hold?

Qiagen has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 5 hold ratings and 0 sell ratings.

What is Qiagen’s share price target?

The average share price target for Qiagen is 45.27. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €50.04 ,and the lowest forecast is €39.03. The average share price target represents 5.85% Increase from the current price of €42.77.

What do analysts say about Qiagen?

Qiagen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Qiagen?

To buy shares of DE:QIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Qiagen (QIA) Stock Forecast & Price Target

QIA Analyst Ratings

QIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

QIA Analyst Recommendation Trends

QIA Financial Forecast

QIA Earnings Forecast

QIA Sales Forecast

QIA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts